Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Reubi

Showing results (151-160 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 1, 1992
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growthJ W Koper, R Markstein, C Kohler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotideH J Wester, M Schottelius, K Scheidhauer, et al.
International Journal of Cancer|April 1, 1992
In vitro and in vivo detection of somatostatin receptors in human malignant lymphomasJ C Reubi, B Waser, M van Hagen, et al.
European Journal of Nuclear Medicine|July 15, 1998
Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptakeE Garin, A Devillers, J Le Cloirec, et al.
Journal of Neuro-Oncology|April 16, 1998
A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastomaH L Müller, M C Frühwald, M Scheubeck, et al.
Blood|October 1, 1993
In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissueJ C Reubi, B Waser, U Horisberger, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatinJ Pless, W Bauer, U Briner, et al.
Cancer Research|August 1, 1996
Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonistH Zia, T Hida, S Jakowlew, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 10, 2007
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapyM Melis, F Forrer, A Capello, et al.
European Journal of Nuclear Medicine|June 18, 1998
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivoJ C Reubi, B Waser, J C Schaer, et al.
Pageof 21

Showing results (151-160 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Endocrinology and Metabolism|March 1, 1992
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growthJ W Koper, R Markstein, C Kohler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotideH J Wester, M Schottelius, K Scheidhauer, et al.
International Journal of Cancer|April 1, 1992
In vitro and in vivo detection of somatostatin receptors in human malignant lymphomasJ C Reubi, B Waser, M van Hagen, et al.
European Journal of Nuclear Medicine|July 15, 1998
Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptakeE Garin, A Devillers, J Le Cloirec, et al.
Journal of Neuro-Oncology|April 16, 1998
A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastomaH L Müller, M C Frühwald, M Scheubeck, et al.
Blood|October 1, 1993
In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissueJ C Reubi, B Waser, U Horisberger, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1986
Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatinJ Pless, W Bauer, U Briner, et al.
Cancer Research|August 1, 1996
Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonistH Zia, T Hida, S Jakowlew, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 10, 2007
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapyM Melis, F Forrer, A Capello, et al.
European Journal of Nuclear Medicine|June 18, 1998
Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivoJ C Reubi, B Waser, J C Schaer, et al.
Pageof 21